Government Price Setting for Prescription Drugs Means Less Availability, Higher Prices | Bob Moffit

Posted

September 24, 2021

Views

501

Likes

56

Comments

5

Engagement

12.18%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Heritage's Bob Moffit joined Newsmax on September 23, 2021 to talk about the Democrats' proposal to have the government control the prices for Medicare prescription drugs as part of a week-long series on Medicare.

Read more about this issue here

Bob Moffit is a senior fellow in Domestic Policy Studies at The Heritage Foundation. He has long has specialized in health care and entitlement programs, especially Medicare. He brings to the reform effort his government experience as a senior official of the U.S. Department of Health and Human Services (HHS) and the Office of Personnel Management (OPM) during the Reagan administration.

Check out his work here

Still haven’t subscribed to The Heritage Foundation on YouTube? Click here ►

Follow The Heritage Foundation on Facebook:

Follow The Heritage Foundation on Twitter

Follow The Heritage Foundation on Instagram

Guests & Subjects Covered

Heritage's Bob MoffitMedicare ReadBob MoffitDomestic Policy StudiesThe Heritage Foundation HeMedicare HeUS DepartmentHuman Services HHS

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Government Price Setting for Prescription Drugs Means Less Availability, Higher Prices | Bob Moffit · The Heritage Foundation · Sentinel